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ABSTRACT 
The practice-improvement project (PIP) assessed five family nurse practitioners and one 
pediatrician regarding the use and evaluation of a community treatment guideline packet.  
Attention deficit hyperactivity disorder (ADHD) is a commonly diagnosed, chronic, 
neurobehavioral disorder, and high-quality, evidence-based management is associated with 
improved outcomes. Research has shown an increase in the diagnosis rate for ADHD, and the 
need for intensified clinical management of children, 4-11 years of age, with ADHD. Without 
proper evaluation or management of ADHD symptoms, the child may continue to struggle 
throughout life. Family nurse practitioners (FNPs) employed in rural communities may be the 
first point of contact for children, 4-11 years of age, who present with ADHD 
symptoms. Providers need to be knowledgeable about ADHD, the treatment guidelines, 
community resources, and the proper referrals within the community.  
The PIP was designed to assist providers in 5 Minnesota communities who see 4-11 year- 
old children with ADHD symptoms. The PIP design included the creation and presentation of a 
treatment-guideline packet for 5 FNPs and 1 pediatrician in the rural communities. The 
providers volunteered to utilize and evaluate the packet for 6 weeks in January and February, 
2014. To evaluate the treatment-guideline packet, a post-questionnaire was completed by each 
provider who participated.   
The practice improvement project results indicated that 100% (n=6) of the providers felt 
that the treatment-guideline packet was helpful and would benefit practice. Providers felt the 
packet addressed a practice need by containing both a community resource/referral algorithm and 
an evidence-based ADHD process-of-care algorithm. Three-fourths of the providers felt that 
using the Vanderbilt Assessment Scales for diagnosing children would be a helpful addition to 
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the packet to assist with diagnosing ADHD in children of this age group. Overall, providers felt 
that being more aware of the potential referrals and resources in the community would allow a 
multi-modal approach of care, therefore improving their management of children, ages 4-11, 
with ADHD.  
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CHAPTER 1. INTRODUCTION 
Attention deficit hyperactivity disorder (ADHD) is a commonly diagnosed chronic 
neurobehavioral disorder that is characterized with symptoms of inattention, inappropriate 
behaviors, and impulsivity that can continue into adulthood (American Psychiatric Association, 
2010; National Institute of Neurological Disorders and Stroke, 2011). Research has shown more 
diagnoses of ADHD, and there has been an intensified need to clinically manage these children 
in an effective, timely manner. The child who is 4-11 years of age with symptoms of ADHD 
may not be able to sit still, may have persistent difficulty sustaining attention, and may be 
unable to follow directions. With increased concern about the implications of these ADHD 
symptoms in children, what, then, are the risks of not treating these children? Children without 
proper evaluation, diagnosis or management of ADHD symptoms may continue to struggle 
throughout life. Improper management of ADHD symptoms can have a profound effect on 
financial costs; it can have a negative impact on the individual’s family relationships, peer 
relationships, self-esteem, overall health and safety, as well as the ability to learn and make age-
appropriate behavioral and academic progress.  
Statement of the Problem 
Family nurse practitioners employed in rural communities may be the first point of 
contact for children who present with symptoms of ADHD. Today there is a high prevalence of 
mental health needs with 1 in 5 American children diagnosed with a mental disorder, such as 
ADHD and only 20-25% of these children receiving treatment (American Academy of Child 
and Adolescent Psychiatry, 2009). The diagnosis and management of ADHD can be 
complicated, and the primary-care provider may not have knowledge or awareness about the 
treatment guidelines and what referral resources are needed to deliver the highest quality of care 
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to children ages 4-11. According to the American Academy of Pediatrics (AAP), the updated 
guidelines recommend that primary-care providers (PCP), such as the family nurse practitioner 
(FNP), are responsible for evaluating all children 4-18 years of age, with ADHD symptoms 
(AAP, 2011b). The AAP treatment guidelines provide high-quality, evidence-based, and 
comprehensive care.   
The practice-improvement project (PIP) addresses the complex and collaborative nature 
of ADHD for the evaluation, treatment, and management of children. The FNP working with 
this patient population must have an adequate understanding of ADHD to guide and manage the 
patients and their families. Evaluating and diagnosing ADHD in children can be difficult and 
complex. The ADHD disorder has high rates of comorbid disorders and associated 
psychopathology. It is important for the FNP to be knowledgeable about ADHD, the treatment 
guidelines, available resources, and with whom to collaborate and correctly refer the child for 
successful management. Without knowledge and access to adequate resources, and referrals, 
care can become fragmented, resulting in suboptimal care for children.  
Significance for Family Nurse Practitioners 
The family nurse practitioner as a PCP in rural, primary-care settings needs to be 
knowledgeable about ADHD. The PCP has to be knowledgeable with both the updated 
American Academy of Pediatrics (AAP) guidelines as well as the proper community resources 
and referrals that are available to effectively manage children who are, 4-11 years of age, and 
have ADHD. Collaboration with the correct community stakeholders will ensure that the child 
is treated early and efficiently. Fundamentally, the FNP needs to stay current with the best 
evidence-based practice to effectively address parental concerns and to know when to refer the 
child to a specialist.  
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The FNP as a PCP is in a position to initiate an evaluation for any child, 4-18 years of 
age, with ADHD symptoms according to the practice guidelines. Many PCPs who practice in 
rural communities are confronted with children who have ADHD symptoms at varying levels of 
ages and severities. Many preschool-aged children may not have reached their developmental 
threshold and are a challenge for the PCP who is evaluating for ADHD symptoms. Preschool-
aged children, typically, are impulsive and have trouble sitting still or sustaining attention for 
long periods of time. Therefore, the primary-care provider may find it difficult to accurately 
evaluate ADHD symptoms in the preschool-aged child.  However, research suggests that early 
treatment is important and helpful for the child and the family who will deal with the ADHD 
symptoms.  
Significantly, it is of utmost importance for all PCPs to be familiar with the most-current 
practice guidelines to provide the basis for high-quality, evidence-based care. The PCPs can 
bear the sole responsibility of evaluating, diagnosing, and managing a child with ADHD if they 
feel comfortable. If a PCP is not comfortable with the sole responsibility for the diagnosis or 
management of the child, the PCP should collaborate with subspecialists, such as child 
psychologists or mental-health providers, to ensure that the child receives consistent, 
appropriate management for this disorder and comorbidities (AAP, 2011a).  
The guidelines recommend that the PCPs, such as FNPs, collect a history of presenting 
symptoms which include: a relevant past and family medical history of ADHD, any cardiac 
problems, or unexplained sudden deaths; a review of systems to consider other conditions or 
comorbidities that may present as ADHD or-coexist with ADHD; a thorough physical 
examination, which includes height, weight, blood pressure, heart rate, vision, hearing, and 
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neurologic assessments; and a review of validated assessment scales, including a comorbidity 
screen (AAP, 2011a).  
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CHAPTER 2. REVIEW OF LITERATURE 
Attention Deficit Hyperactive Disorder (ADHD) 
Attention deficit hyperactivity disorder (ADHD) is a common chronic neurobehavioral 
disorder that is diagnosed in children and can continue into adulthood (American Psychiatric 
Association, 2010; National Institute of Neurological Disorders and Stroke, 2011). ADHD is a 
medical condition that is commonly recognized in childhood and is characterized by the 
symptoms of inattention and/or hyperactivity-impulsivity (Krull, 2014). The child with ADHD 
has developmentally inappropriate behaviors of inattention, hyperactivity and impulsivity that 
are not typically observed in children at the same level of development (American Psychiatric 
Association, 2010; National Institute of Neurological Disorders and Stroke, 2011). Proper 
management of ADHD is important or it can have a profound effect on a child’s behavioral, 
emotional, social, cognitive and academic functioning in multiple setting of life (Hodgkins, 
Dittmann, Sorooshian & Banaschewski, 2013; Krull, 2014).  
ADHD is a complex disorder that is managed by educating the patient and family and by 
using medications and/or cognitive behavioral therapy (GroupHealth, 2011). One of the largest 
studies done was the Multimodal Treatment Study of Children with ADHD (MTA), which was 
the first conducted by the National Institute of Mental Health, which examined the long-term 
effectiveness of medication versus behavioral treatment versus both treatments for ADHD 
(Arnold et al., 1997). The study found that medication alone was effective and sufficient 
treatment, however, combining behavioral treatment with medication management allowed 
children to be on lower doses of medications to adequately control the ADHD symptoms. The 
MTA study provided important information about needed guidelines from professional 
organizations. 
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Specialists in behavioral health, neuropsychology, and pediatrics, are often consulted by 
the primary-care provider to assist in the care of a child with ADHD. The main reason to use 
resources and referrals in health-care is the impairments associated with ADHD, such as 
comorbidities, the patient’s age, the ADHD subtype, the treatment response history, as well as 
the treatment needs and goals of the patient and family (Hodgkins et al., 2013). Significantly, 
the AAP (2011a) developed a valuable resource: an ADHD toolkit for primary-care providers 
who manage children with ADHD symptoms. The toolkit was developed to assist the providers 
with the management of ADHD symptoms. Providers need to address each individual’s 
medical, psychosocial, and developmental issues in order; to rule out, for example, any toxins, 
comorbidities or auditory or sensory processing disorders. The toolkit is placed within a clinical 
framework that allows PCPs, in collaboration with other disciplines, to manage and provide the 
best care possible for each child with ADHD symptoms.  
Prevalence of ADHD 
Today, more children are being diagnosed with ADHD. Statistics have shown that 
approximately 5-10% of U.S. children are diagnosed with ADHD (American Psychiatric 
Association, 2010; Nagui, 2009). According to the Center for Disease Control and Prevention 
(2011), the 2010 statistics for U.S. children, 3-17 years of age, who have been diagnosed with 
ADHD, are approximately 5.2 million. Overall, boys have been found to be 2.4-4 times more 
likely than girls to have ADHD symptoms in the United States (Center for Disease Control and 
Prevention, 2011; Nagui, 2009). The ADHD disorder has been found to be present around the 
world, and it is believed that some children may not outgrow the disorder, making it a chronic 
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condition. It is significant for the PCP who will be responsible to manage the disorder into 
adulthood.  
Etiology of ADHD 
The problem with ADHD for clinicians is that there is no exact etiology, but the disorder 
is believed to have both genetic and environmental factors. The environmental factors are 
believed to include central nervous system (CNS) injuries either at birth or after, viral 
infections, low birth weight, fetal alcohol syndrome, perinatal stress, hypoxia, lead, smoking 
during pregnancy, and other toxins (Millichap, 2008). The molecular-genetic studies have found 
a relationship between the dopamine transporter (DAT1) gene and ADHD, however, the 
mechanism of its effect is unknown (Durston et al., 2008). ADHD’s genetic factors are believed 
to be an impairment of the dopaminergic and noradrenergic transmission studies have found 
that the basal ganglia are significantly smaller in children with ADHD (Durston et al., 2008) 
The study also found that the DAT1 binding ration in the basal ganglia was significantly 
increased in children with ADHD who were not receiving treatment for the disorder (Durston et 
al., 2008). A study done by Shaw et al. (2007), examining 223 children and adolescents with 
ADHD, found that, by measuring the cortical thickness of children with ADHD, the overall 
development pattern was similar; however, there was a delay in cortical maturation. The study 
found delays in cognitive processes, such as attention and motor planning, which were 
predominately seen in the prefrontal regions of the brain (Shaw et al, 2007). The study showed 
that the cognitive delays for children reaching their milestones were 10.5 years compared to the 
median age of 7.5 years (Shaw et al., 2007).  
On the other end of the spectrum, there has been extensive research on families, twins, 
and adopted children to support the theory that ADHD is a highly heritable disorder 
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(Banaschewski, Becker, Scherag, Franke, & Coghill, 2010). Studies have found that 
approximately 75-76% of children with ADHD also had first-or second-degree relatives with a 
history of ADHD (Banaschewski et al., 2010; Freitag, Rohde, Lempp, & Romanos, 2010).  
Twin studies have shown that there is, in fact, a strong genetic, heritable component that may 
play a significant role in the development of ADHD. Monozygotic twins have an increased 
incidence of ADHD when compared with dizygotic twins. In the studies, the quantitative traits 
are analyzed by comparing phenotypic variance between monozygotic (MZ) twins who shared 
100% of their DNA and dizygotic (DZ) twins who share 50% of their distinguished DNA 
(Beaver, Nedelec, Rowland,  & Schwartz, 2012). If the environmental experiences between the 
MZ and DZ twins are similar, then the only reason that MZ twins should be more similar than 
DZ twins on ADHD and ADHD-like symptoms is because they share more genetic material 
(Beaver et al., 2012).   
Studies with sibling pairs, such as full siblings, half siblings, and stepsiblings, also 
illustrated the strong genetic association in families. Studies were also done with adopted 
children who had ADHD symptoms, and the results were consistent with twin-based studies. 
The results of these studies revealed a significant association between ADHD symptoms in 
biological parents and ADHD symptoms in their adopted-away children (Beaver et al., 2012). 
Genetics may, in fact, be the primary factor associated with ADHD while environmental factors 
are a secondary reason. 
Comorbidities  
When a child is diagnosed with ADHD, the PCP must take into account that the disorder 
has been found to present with high rates of comorbid disorders and associated 
psychopathology. Approximately 70% of preschool-aged children diagnosed with ADHD 
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symptoms may have at least one other co-morbid diagnosis (Nagui, 2009). According to Freitag 
et al. (2010), a study done with twins found that approximately 90% of the children who had 
ADHD were affected by at least one comorbid disorder. The most prevalent comorbid disorders 
found in the studies included oppositional defiant disorder, 40-65%; conduct disorder, 27-47%; 
major depressive disorder, 0-24%; and generalized anxiety disorder, 13-21% (Freitag et al., 
2010).  
Health-care providers should collect a history of presenting symptoms, relevant past and 
family medical history, and a review of systems to consider other conditions or comorbidities 
that may present as ADHD or coexist with ADHD (AAP, 2011a). The PCP who is 
uncomfortable with a child, with the symptoms of ADHD, and/or with other comorbidities 
needs to refer the child to a specialist for the correct diagnosis.     
Diagnostic Criteria for Attention Deficit Hyperactivity Disorder 
  Primary-care providers need to be aware of how ADHD is diagnosed using the 
Diagnostic and Statistical Manual of Mental Disorders (5th ed.; DSM-5) criteria that were 
released in May 2013 from the American Psychiatric Association. According to the American 
Psychiatric Association (2013), the DSM-5 is used to diagnose children and adults with ADHD. 
The ADHD diagnosis includes the symptoms of inattentiveness or hyperactivity-impulsivity 
(Table 1) in 2 or more environmental settings before the age of 12 years (American Psychiatric 
Association, 2013). The diagnosis of ADHD is that children must have 6 or more symptoms 
from either (or both) of the inattention and the hyperactivity-impulsivity criteria. The symptoms 
must have persisted for at least 6 months, must have shown maladaptation and inconsistency 
with the child’s developmental level, and must directly affect the child negatively in social and 
academic activities (American Psychiatric Association, 2013).  
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The three subtypes of ADHD are hyperactive-impulsive, inattentive, and the combined 
type. The hyperactive-impulsive subtypes contain six or more symptoms that are found in the 
hyperactivity-impulsivity categories. The inattentive-subtypes contain six or more symptoms 
from the inattention category. The combined type is diagnosed when both the hyperactive-
impulsive subtype and the inattentive subtype symptoms are present in each category (American 
Psychiatric Association, 2013). 
Table 1 
ADHD Symptoms (Adapted from American Psychiatric Association, 2013) 
Inattention Symptoms Hyperactivity and Impulsivity Symptoms 
Fails to give close attention to details or makes 
careless mistakes with schoolwork, work, or 
other activities. 
 
Often fidgets with hands or feet, or squirms 
in seat. 
Often has difficulty remaining focused and 
sustaining attention in tasks. 
 
Often leaves seat in classroom or in other 
situations where expected to remain seated. 
Does not seem to listen when spoken to 
directly. 
Often runs about or climbs excessively in 
situations where it is inappropriate. 
 
Often does not follow through on instructions 
and fails to finish schoolwork or activities at 
home or school. 
 
Has difficulty with playing or engaging in 
leisure activities quietly. 
Often will have difficulty organizing tasks and 
activities. 
 
Is often continuously on the go as if driven 
by a motor. 
 
Avoids, dislikes, or is reluctant to engage in 
tasks that require a lot of mental effort. 
 
Often talks excessively. 
Loses things that are necessary for tasks or 
activities. 
 
Often blurts out answers before questions 
have been completed. 
Is easily distracted by extraneous stimuli. 
 
Often has difficulty waiting his or her turn. 
Is forgetful in daily activities. 
 
Interrupts or intrudes on others’ play or 
conversations. 
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Clinical Practice Guidelines  
The American Academy of Pediatrics has guidelines that are recommended for primary-
care providers to evaluate children from 4-18 years of age who present with symptoms of 
hyperactivity, inattention, or impulsivity and who have behavioral or academic problems (AAP, 
2011b). The clinical guidelines recommend that PCPs collect a history of presenting symptoms; 
relevant past and family medical history;  a review of systems to consider other conditions or 
comorbidities that may present as ADHD or-coexist with ADHD; a physical examination, 
including vision, hearing, and neurologic exams; and a review of validated assessment scales, 
including a comorbidity screen (AAP, 2011a).  
The AAP (2011b) guidelines recommended evaluating children as young as 4 years of 
age and using behavioral therapy as the first-line treatment for 4-5 year olds. The treatment 
recommendations for children 6-11 years of age included FDA-approved medications and/or 
teacher-administered behavior therapy as a first-line treatment (AAP, 2011b; Center for Disease 
Control and Prevention, 2011). The guidelines were recommended for high-quality, evidence-
based healthcare practices. The guidelines were developed with the collaboration of 
representatives from the American Academy of Pediatrics and several professional 
subcommittee participants; the American Academy of Child and Adolescent Psychiatry, the 
National Association of School Psychologists, the Society for Developmental Behavioral 
Pediatrics, the American Academy of Family Physicians, epidemiologists from the Center for 
Disease Control and Prevention (CDC), Children and Adults with Attention-
Deficit/Hyperactivity Disorder (CHADD), and the Society for Pediatric Psychology (AAP, 
2011b). These groups collaborated over a 2-year period using a multi-level, systematic approach 
that reviewed the evidence base for practice changes that occurred since the development of the 
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previous guidelines that addressed the diagnosis and treatment of children who were 6-12 years 
of age. With the treatment guidelines, a health plan will be useful and beneficial to direct 
primary-care providers. 
The ADHD Toolkit 
The ADHD toolkit from the American Academy of Pediatrics (AAP, 2011a) is an 
important resource for PCPs who are considering an individual’s medical, psychosocial, and 
developmental factors when assessing for ADHD. Recently, the ADHD toolkit has been 
updated according to the new practice guidelines. The toolkit is designed to assist PCPs with the 
assessment and ongoing management of children who are 4-18 years of age. The toolkit 
includes the Vanderbilt Rating Scales which are useful to assess ADHD symptoms in pediatric 
patients (AAP, 2011a). The toolkit has evidence-based guidelines and evaluation tools, such as 
an algorithm with step-by-step guidance for the process-of-care for children with ADHD 
(Appendix A). Tools available in the ADHD toolkit include the National Initiative for 
Children’s Healthcare Quality (NICHQ) Vanderbilt assessment scales which are useful to assess 
ADHD symptoms in pediatric patients, these questionnaires are completed by the child’s 
parents and teachers. The ADHD toolkit also has scoring instructions for the NICHQ Vanderbilt 
assessment scales, two samples of ADHD management plans, tools to screen for comorbidities, 
and information and resources to support the parents of children with ADHD symptoms (AAP, 
2011a).    
Vanderbilt Rating Scales 
The Vanderbilt Rating Scales (VARS) are recommended by the ADHD toolkit so that 
parents and teachers can assist the clinician with the diagnosis and management of a child who 
has ADHD symptoms. Parents and teachers are important stakeholders in the child’s care; they 
   
13 
 
play an integral role for identifying symptoms associated with ADHD and should document 
observations made both in the child’s personal life and in the school environment. The VARS is 
useful for PCPs to rule out any alternative causes for the symptoms and to assess for other 
conditions that might coexist with the ADHD diagnosis. The toolkit is customized to closely 
follow the criteria set forth in the DSM-IV and includes 18 ADHD symptoms that are reported 
in the DSM-IV (Langberg, Vaughn, Brinkman, Froehlich, & Epstein, 2010). The VARS is 
scored using a 4-point Likert scale that indicates whether each ADHD symptom occurs never 
(score 0), occasionally (score 1), often (score 2), or many times (score 3). The child can then be 
scored by the clinician and categorized, according to symptoms, into a subtype: inattentive, 
hyperactive/impulsive, or combined (Langberg et al., 2010).  
The second section of the VARS includes performance items where parents and teachers 
rate 8 partially overlapping, functional impairment items (Langberg et al., 2010). This section is 
rated on a 5-point Likert scale with excellence (score 1), above average (score 2), average (score 
3), somewhat problematic (score 4), or problematic (score 5) on the scale (Appendices F and 
G). VARS data have no reliable research about the validity for how this tool may identify 
children with potential learning disorders. The clinician should then refer the child to a 
psychologist to complete a psycho-educational evaluation (Langberg et al., 2010). 
Cognitive Behavior Therapy/Cognitive Behavioral Parental Training 
According to the AAP (2011a), evidence-based cognitive behavioral training (CBT) 
programs (Table 2) have been found to be effective through research and have been 
recommended as a first-line treatment option for preschool-aged children with ADHD 
symptoms and as an alternative or combination of treatment for older children. The assessment 
of behavior functioning as a basis for intervention selection needs to be tailored to the 
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individual child in order to improve the treatment’s effectiveness for the symptoms (Cormier, 
2009). According to McGuinness (2008), cognitive behavioral therapy includes a set of specific 
interventions which provide goals for modifying the physical and social environments for a 
child with ADHD symptoms.  
Cognitive behavioral parental training (CBPT) is therapy that is implemented by 
educating and training parents how to use skills to help manage a child with non-compliant 
behavioral symptoms of ADHD (AAP, 2011b; Young & Amarasinghe, 2010). School-based 
cognitive behavioral modifications are also part of treatment that is similar to CBPT, but 
interventions are made by the teacher, parents, peers, and students themselves (AAP, 2011a). 
Parents and special educators learn how to reward positive behaviors through praise, positive 
attention, and tangible rewards, as well as how to ignore bad behaviors with time outs, other 
effective commands, and similar physical disciplinary techniques (Glasser & Easley, 2008; 
Young & Amarasinghe, 2010).  
Today, CBT is viewed as a well-established, empirically supported psychosocial 
treatment for a child with ADHD. Research has shown that CBPT has been the most broadly 
investigated treatment for ADHD-related behavioral problems and that it is the most effective 
treatment (Young & Amarasinghe, 2010). CBPT techniques are beneficial to the family and the 
child by improving both child behavior and the maladaptive parenting behavior (Chronis, 
Chacko, Fabiano, Wymbs, & Pelham, Jr., 2004; Cormier, 2009). Cognitive behavioral therapy 
programs are helpful for the child who has non-compliant behaviors that are associated with 
ADHD not only in the home environment, but also in other environments the child encounters. 
The assessment of behavior intervention selection needs to be tailored to the individual child to 
improve the treatment’s effectiveness (Cormier, 2009).  
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Table 2 
Evidence-Based Cognitive Behavioral Treatment for ADHD (Adapted from AAP, 2011b) 
  
Medication Treatment for Children with ADHD 
 Stimulants are still the most commonly prescribed medications for children with ADHD.  
Stimulants such as Ritalin, Adderall, and Dexedrine have been found to be safe and effective, as 
well as non-stimulants such as Atomoxetine (Strattera) as a first-line medication in treating the 
symptoms of ADHD. Stimulants and non-stimulants all have warnings for side effects. The 
most commonly reported side effects are decreased appetite, weight loss, sleep problems, 
anxiety, and irritability while less-common side effects may include tics and personality 
changes, such as a flat affect or being without emotion (National Institute of Mental Health, 
2011). According to Berman, Kuczenski, McCracken and London (2008), amphetamines have 
been used medically for years; however recreational abuse is also a potential result with 
stimulants and is a growing concern. Treatment with stimulants that is started early in young 
children has been linked to slower metabolic rates, slowed growth of height and weight, and 
 
Types of 
Interventions 
 
Description of Treatment 
for Children with ADHD 
 
 
Typical Outcome(s) 
Cognitive behavioral 
parent training 
(CBPT) 
Cognitive behavior-modification 
principles provided to parents for 
the home setting. 
Improved compliance with 
parental commands and improved 
parental understanding of 
behavioral principles that have 
high levels of parental satisfaction 
with treatment.  
Cognitive behavioral 
classroom 
management 
Cognitive behavior-modification 
principles provided to teachers 
for the classroom setting. 
Improved attention to instruction, 
improved compliance with 
classroom rules, decreased 
disruptive behavior, and improved 
work productivity.  
   
16 
 
less influence on the ADHD symptoms (AAP, 2011a; Berman et al., 2008). Healthcare 
providers who have pediatric patients on stimulants, non-stimulants and antidepressants need to 
closely monitor these children for side effects.  Appendix F is a list of stimulant and non-
stimulant medications that are approved by the U.S. Food and Drug Administration (FDA) for 
children with ADHD symptoms; the medications are listed by age group and side effects.   
The FDA recommends that primary-care providers obtain a complete initial health, 
family history, and physical for any existing cardiovascular and psychiatric problems before 
referring the child to behavioral mental-health professionals or starting him/her on medications 
(National Institute of Mental Health, 2011). The American Heart Association (2011) 
recommends that children have a cardiac evaluation, including an electrocardiogram, before 
starting treatment with stimulant medications to rule out heart abnormalities. Stimulant 
medication should not be used with children or adults who have pre-existing heart conditions or 
structural heart problems.  
Because there is no evidence about the long-term impacts for the child who is prescribed 
ADHD medications by the subspecialist, close monitoring by the PCP and the parents needs to 
take place. Studies about the effect on a developing brain are a concern when using Ritalin 
which might interfere with normal brain development in younger children (National Institute of 
Mental Health, 2011). For children with a personal history of depression, bipolar disorder, or 
suicide, it is important to carefully monitor the child for safety (National Institute of Mental 
Health, 2011). The medications have been found, in some cases, to cause hostility, aggression, 
anxiety, depression, and paranoia. Research is ongoing about the benefits and risks of specific 
ADHD medications. Many professionals and individuals in the community believe that 
medication should not be the primary option for treating ADHD (Jenkins, 2010).   
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Comprehensive Treatment Team 
Collaborating with stakeholders is important for treatment options that are in the best 
interest of the child to prevent comorbidities and delays with developmental milestones.  
The family nurse practitioner (FNP) plays a major role in managing ADHD and has the 
responsibility to assist the patient and family with a treatment plan that has the proper resources, 
referrals, and team players. As a primary-care provider in the community, it is important to 
identify the patient’s needs and to collaborate with mental-health behavior professionals, such 
as the psychologist, psychiatrists, and mental-health therapists. Other stakeholders may include 
pediatricians, special educators, area schools, clinics, and organizations in the community.    
Special Education and Accommodations  
 To assist in the management of children with ADHD, there are special education 
programs and accommodations for children who have ADHD and who are considered to be 
disabled. Federal law indicates that all students with disabilities are entitled to a free education 
in the least restrictive learning environment (Laughlin, 2012). According to the AAP (2011b), 
these special-education services include the Individualized Education Plan (IEP) and the 504 
Plan which are reserved for a child with a disability such as ADHD. When a child is diagnosed 
with ADHD, it is important for the PCP to collaborate with the parents and the school to 
provide special-education services and accommodations for the child. First, the parents or 
guardians need to request an educational evaluation for the child. The provider then needs to 
provide a letter to the school confirming the child’s diagnosis (AAP, 2011b). Special educators 
at the school are qualified to teach techniques for succeeding in school and are trained to 
provide accommodations.   
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The Plan Do Study Act Improvement Model 
The practice improvement project (PIP) is aimed at making a positive change to clinical 
practice in the rural communities of northwestern Minnesota. To make improvements in clinical 
practice there has to be desire for change. A suitable model to improve practice that has gained 
popularity in health-care is Plan Do Study Act (PDSA). The PDSA is an evidence-based 
scientific method that is part of the Institute for Healthcare Improvement Model. The model is 
used to determine if there is a need for change and if the change in practice leads to an 
improvement in healthcare (Agency for Healthcare Research and Quality, 2012). The model has 
been useful for hundreds of health-care organizations to improve practice (Hughes, 2008; 
Institute for Healthcare Improvement, 2011). The PDSA is an action-oriented cycle that will 
continuously test any changes and has been found useful by health care to test change in 
practice (Agency for Healthcare Research and Quality, 2012).   
The PDSA cycle is a systematic series of steps to gain knowledge for the continual 
improvement of the health care process (Hughes, 2008). The PDSA improvement model has 
three fundamental questions to start a planned approach: (1) What is the goal of the project (2) 
How will we know if a change is an improvement (3) What changes can be made for 
improvement (Institute for Healthcare Improvement, 2011). Once there is a decision about what 
is to be achieved, the PDSA cycles can be implemented. 
 The PDSA model (Figure 1) consists of four stages that will be used to test the practice 
improvement project on a small scale first which is the goal to determine if the packet will 
improve practice (Institute for Healthcare Improvement, 2011). The PDSA cycles are as 
follows: (a) The Plan stage details what is to be implemented for an improvement. At this stage 
of the PIP the barriers to healthcare may be the lack of knowledge about referrals and resources 
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in the community. (b) The second stage is the Do stage where the improvement project is in 
process on a small scale. At this stage of the PIP, primary-care providers are asked to consent to 
using the algorithm in their practice to manage children who are 4-11 years of age and have 
ADHD. (c) The third stage, the Study stage, examines the results of the implementation. This 
stage interprets what the study has shown and what is learned, aiming to build on the knowledge 
for improvement (Agency for Healthcare Research and Quality, 2012; Institute for Innovation 
and Improvement, 2013). At this stage of the PIP, one would analyze how change can benefit 
practice and if any change is needed to further improve practice. (d) The fourth and final stage 
is the Act stage where one plans the next change cycle or full implementation. If improvement 
is found with the change, then implementation is possible. If, however, the change does not 
cause an improvement, there must be a need for another change for improvement which then 
leads to a new PDSA cycle (Figure 1). 
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Figure 1. The Plan Do Study Act improvement model (Adapted from the Institute for 
Innovation and Improvement, 2013). 
 
 
Plan 
Do 
Study 
Act 
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CHAPTER 3. PROJECT OBJECTIVES, DESIGN, AND METHODS   
Population and Setting  
The population of interest included family nurse practitioners who see children and a 
pediatrician who specializes in ADHD; they were in positions to evaluate and manage children, 
4-11 years of age, for ADHD symptoms in the selected rural northwestern Minnesota region. 
The selected rural community settings in northwestern Minnesota included Detroit Lakes, 
Frazee, Perham, New York Mills, and Otter Tail. As a provider in this position, it is important 
to be knowledgeable about evidence-based guidelines; resources available in the area; and 
when, where, and to whom to refer children with ADHD symptoms.  
Design and Methods 
The PIP design was a small pilot study that included the development and presentation 
of a treatment-guideline packet to manage children with ADHD for specific health-care 
providers who care for children. The purpose of conducting a pilot study was to test the PIP 
design using the PDSA model. The PDSA cycles start with a small study and make adjustments 
before committing the design to a larger study. After receiving verbal approval from facility 
administrators and the practitioners, the treatment-guideline packet was presented and 
distributed in mid-December, 2013 to 5 FNPs and a pediatrician who care for children in the 
selected communities. The packet was designed to assist them with resources and referrals 
about when, who, and where to refer children who were 4-11 years of age and being managed 
for ADHD. The packet included a resource/referral algorithm, the ADHD care-process 
algorithm from the AAP, and a list of medications specific to ADHD. The packet was given to 
providers who agreed to utilize and evaluate the algorithm for approximately 6 weeks to 
determine if it was useful in practice to assist with managing children who were 4-11 and had 
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ADHD symptoms. After the 6-week trial period, the FNPs and the pediatrician were given a 
questionnaire regarding how the packet was useful and/or if it did or could improve practice 
when managing children with ADHD symptoms. The questionnaire asked the providers for any 
input about improving the packet or algorithm. A follow-up interview was completed with the 
participating providers who needed to clarify any of their written answers.  
Healthcare Algorithms 
Algorithms are used throughout healthcare as a helpful tool in practice. The project 
utilized the use of algorithms to ensure that healthcare provider did not forget the essential 
elements of care in practice (Svirbely & Iyengar, 2009). The packet contained two algorithms 
that were easy to follow with evidence-based guidelines as well as recent resources and proper 
referrals in the community to be used by healthcare providers managing children, 4-11 years of 
age, with ADHD symptoms. One algorithm was provided by the AAP with standard-of-care 
practice guidelines that provided manageable steps throughout the care process with key actions 
for primary-care providers to follow (AAP, 2011b). The second algorithm was designed by the 
researcher, in collaboration with mental healthcare facilities and providers in the community, to 
illustrate the available resources and proper referrals with the available appointments and 
average waiting times. Algorithms used in healthcare are valuable and beneficial because they 
support medical decisions, use evidence-based guidelines, increase the accuracy of diagnosis 
and prognosis, and increase the scope of practice for providers while reducing subjective 
judgment and medical errors (Svirbely & Iyengar, 2009).                       
The Objectives of the Practice-Improvement Project 
The goal of the practice-improvement project (PIP) was to provide a treatment-guideline 
packet that contained two algorithms, the American Academy of Pediatrics’ ADHD algorithm 
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and an algorithm with the proper community resources and referrals. The packet would be used 
by 5 FNPs and a pediatrician who see children in the rural northwestern Minnesota region. The 
FNPs and the pediatrician agreed to participate in the PIP and were provided a treatment-
guideline packet that included an area-specific algorithm to assist them with the proper referral 
sources and resources that are available to them. The AAP’s guideline algorithm (Appendix A) 
was included in the health-plan packet to assist with the clinical management of children who 
have ADHD. Knowledge and awareness of the American Academy of Pediatrics’ practice 
guidelines and the resources available in this region were found to be vital for these primary-
care providers who gave evidence-based healthcare to children with ADHD.   
 The PCP who evaluates a child, 4-18 years of age, with symptoms of ADHD may wish 
to refer the child to a psychologist or a mental-health clinician for further evaluation. The PCP 
does continue to have the responsibility to manage the child while collaborating with the 
subspecialists, parents, educators, and other stakeholders in the child’s care. The treatment-
guideline packet allows the participating providers to individualize care using the evidence-
based practice guidelines and the available resources in addition to addressing who may be the 
most appropriate referral according to the needs and abilities of the child and his/her family.   
Project Objectives 
1. Increase the knowledge and use of the evidence-based treatment guidelines set forth by 
the AAP. 
2. Improve the awareness of when and to whom to refer when diagnosing and managing 
ADHD in children who are 4-11 years of age.  
3. Promote the utilization of resources and referrals that are available in the community. 
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4. Present an ADHD treatment-guideline packet to 5 NPs and 1 pediatrician who specialize 
in ADHD in the region; the packet has the AAP guideline algorithm and an algorithm 
listing the available community resources and referrals.  
5. Evaluate the packet’s usefulness as a resource for the FNPs and other primary-care 
providers when managing ADHD in children.  
Evidence-Based Practice Intervention Plan  
Improved implementation of evidence-based practice in the clinical setting entails the 
adoption of new models for managing and improving practice for all PCPs. Evidence-based 
practice means integrating clinical expertise with the best-available external, clinical evidence 
from systematic research (Harris, Roussel, Walters, & Dearman, 2011). According to Lynch, 
Sood, and Chronis (2010), the health-care clinician, such as a family nurse practitioner, may be 
the primary provider for children with ADHD symptoms; however, it has been found that some 
providers do not fully integrate the evidence-based practice of assessment and treatment in their 
practice. The FNP and other primary care providers may need direction and awareness about 
what has been found to be the best-available evidence-based treatment guidelines and to use the 
knowledge from clinical experts to apply high-quality interventions for patient care (U.S. 
National Library of Medicine, 2011). A treatment guideline packet is available to clinicians, 
providing the integration of research, evidence, clinical expertise, resources available, and the 
patient’s/family’s preferences and values in managing each unique child with ADHD. 
IRB Approval and Ethical Considerations 
 Utilizing the ADHD treatment-guideline packet in their practice was voluntary and did 
not pose any risk to the participants. Institutional Review Board (IRB) approval was exempt for 
review and was obtained from North Dakota State University, Essentia Health, and Sanford 
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Health before distributing the resource/referral guidelines to participants. The participants’ 
rights were protected according to IRB, and no identifying information such as the participant’s 
name, age, or address, were found in the results. Any identifying information, was protected and 
only known by the researcher and the chair.  Participation was voluntary, and a written consent 
form was provided to participants along with the importance of their participation in the project 
to determine if using a treatment-guideline packet with a resource/referral algorithm for that 
specific region did or could improve practice. Participants verbally consented to participate and 
were informed that a follow-up phone call may be needed to answer any questions. Participation 
was emphasized as optional; however, there was an emphasis on the importance and benefits of 
the practice-improvement project when managing children, 4-11 years of age, with ADHD.  
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CHAPTER 4. EVALUATION 
Methods of Evaluation  
The research design included creating and presenting a packet to 5 FNPs and 1 
pediatrician. The pediatrician volunteered to use and evaluate the packet because of an interest 
in learning about the community’s available resources and referrals. The PDSA model provided 
the project with a planned set of cycles that are designed to provide the project with what should 
be tested, to test the guideline packet on a small scale, to decide if there was an improvement in 
practice and then to test any changes for a continuous improvement cycle (National Learning 
Consortium, 2013).  
Plan: Step 1 
 Providers and parents have voiced a concern in practice regarding lack of knowledge 
about to whom and to where to refer for assistance in managing 4-11 year old children with 
ADHD symptoms and other mental-health concerns. During the Plan stage, the treatment-
guideline packet was created with the assistance of mental health specialists and facility 
administrators in the region to assist primary care providers in the management of children with 
ADHD.  A treatment-guideline packet that included the most recent practice guidelines from the 
American Academy of Pediatrics (AAP) algorithm, and the proper community resources and 
referrals in practice was developed. It was anticipated that offering providers access to a 
treatment-guideline packet with these resources would ensure that more providers followed 
proper referrals and treatments. 
Do: Step 2 
In second step, the Do cycle, the packet was provided to the 5 FNPs and the 1 
pediatrician who volunteered and agreed to utilize and evaluate the algorithm. The providers 
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then utilized the guideline packet for 6 weeks. After the 6 weeks were completed, a paper post-
questionnaire was administered to the providers who had agreed to participate and utilize the 
treatment-guideline packet. The post-questionnaire contained 7 questions regarding whether the 
information in the treatment-guideline packet was beneficial for the purpose of advancing 
practice. Through trialing the packet in practice, providers were able to determine if they were 
or would be useful in practice to assist in managing children, 4-11 years old with ADHD 
symptoms.  
Study: Step 3 
The third step is the Study cycle. The researcher analyzed the results of the post-
questionnaire after permitting the providers to utilize and evaluate the treatment-guideline 
packet for 6 weeks. The data were collected from the answers given on the questionnaire. 
Additionally, three providers were interviewed by the researcher at the completion of the trial. 
The providers found that the treatment-guideline packet was beneficial for the purpose of 
advancing practice and recommended changes that could improve the packet in practice, as 
further discussed in Chapter Five.  
Act: Step 4 
The feedback provided by participants further develops the treatment-guideline packet 
and are intended to improve the utilization and effectiveness of the packet. The suggestions 
made by participants and the researcher are detailed in Chapter Five. 
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CHAPTER 5. RESULTS 
Presentation of Results 
A total of 6 health care providers who see children utilized and evaluated the treatment-
guideline packet for children with ADHD and then answered the paper post-questionnaire. A 
follow-up phone interview was completed with 2 family nurse practitioners from whom clarity 
regarding their written answers was needed. The project indicated that 100% of the participants 
(n=6) thought that the treatment-guideline packet with a resource/referral guideline was useful 
or would be beneficial in practice when referring or managing children with ADHD. The 
treatment-guideline packet was utilized, to some degree, in practice by 50% (n=3) of the 
participating providers. For the providers who had the opportunity to utilize the packet, the 
primary reason for seeing the children included adequate ADHD symptom control, behavioral 
problems at home and school, and a well-child visit. Three-fourths of the providers felt that the 
Vanderbilt assessment scales for diagnosing children would be a helpful addition to the packet 
to assist with diagnosing ADHD in children of this age group. One respondent did recommend 
adding the Patient Health Questionnaire-9 (PHQ9), which is a depression scale and the Pediatric 
Symptom Checklist-17 (PSC-17) should be used in addition to the Vanderbilt assessment scales 
to assist with general screening for comorbidities and to rule out other mental-health disorder.  
The Vanderbilt assessment scales, the PHQ9, and the PSC-17 are supported by the American 
Academy of Pediatrics (2011a) and are provided in the ADHD toolkit compiled by the 
American Academy of Pediatrics. The Vanderbilt assessment scales are questionnaires that are 
given to both the teacher and the parent to collect information needed for the diagnosis of 
ADHD and any other functional impairments of the child. The Vanderbilt assessment scales are 
intended to screen for external comorbidities, such as conduct disorders, and internalizing 
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disorders, such as depression and anxiety (AAP, 2011a). The PSC-17 is a questionnaire for 
parents that screens for the child’s behavioral disorders.  The PHQ9 is a questionnaire for 
depressive disorders that may be used to identify or follow a patient with depressive disorders 
(AAP, 2011a). The results of the questionnaire given to the providers are shown in Table 3. 
Objectives Achieved 
Objective 1: Increase the knowledge and use of the evidence-based treatment  
guidelines set forth by the AAP. The packet provided the updated AAP evidence-based 
treatment-guideline algorithm and a community resource/referral algorithm for providers who 
participated in the PIP to evaluate and use in practice. Information was collected from the 
participating providers regarding whether the packet was useful for evidence-based 
management and community resources for children, 4-11 years of age, with ADHD symptoms. 
Evidence-based treatment guidelines are systematically developed aids to assist providers in 
choosing appropriate healthcare practices for many patients with specific clinical problems or 
prevention issues (GroupHealth, 2011). Providers must remember that guidelines are not meant 
to replace clinical judgment (GroupHealth, 2011). The questionnaire indicated that 100% (n=6) 
of the participants felt that the packet was useful or could benefit practice with the treatment 
guidelines as well as the resources and proper referrals in the community. To improve the 
packet with evidence-based guidelines, three-fourths of the providers felt that adding the 
Vanderbilt assessment scales for diagnosing children would be beneficial. One provider 
recommended adding the Patient Health Questionnaire-9 (PHQ9) and the Pediatric Symptom 
Checklist-17 (PSC-17) in addition to the Vanderbilt Assessment Scales to assist with general 
screening for comorbidities and to rule out other mental-health problems.  
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Table 3 
Questionnaire Results 
Practitioners Q#1 How 
many 
children 
seen with 
ADHD?  
Q#2 
Reason for 
seeing 
child or 
children? 
Q#3  
Did the 
packet 
address a 
need in 
practice? 
Q#4  
Did the 
packet 
benefit 
practice? 
Q#5 How 
did the 
packet 
not 
benefit 
practice? 
Q#6 
Barriers to 
using the 
algorithms 
Q#7 How to 
improve the 
packet? 
P 1 11 Behavioral 
problems at 
school and 
home 
   Yes   Yes Not      
staying 
within 
the 
network 
None Vanderbilt 
assessment 
scales for 
children 
P2 0 N/A    Yes   Yes Not a big 
pediatric 
clientele 
Keep it up-
to-date 
None 
P3 0 N/A    Yes   Yes None None None 
P4 0 N/A    Yes   Yes None None Vanderbilt 
assessment 
scales for 
children 
P5 1 Well child 
visit 
   Yes   Yes None None Vanderbilt 
assessment 
scales for 
children 
P6 20 Adequate 
ADHD 
symptom 
control  
   Yes   Yes None None Vanderbilt 
assessment 
scales for 
children, 
PHQ9 & PSC 
 
Objective 2: Improve the awareness of when and to whom to refer when diagnosing 
and managing ADHD in children who are 4-11 years of age. Participating providers utilized 
the guideline packet for 6 weeks. At the end of the 6 weeks, 100% (n=6) of the providers felt 
that the AAP ADHD process-of-care algorithm was useful on when to refer the child and that 
the resource/referral algorithm was beneficial for improving practice by having the proper 
community resources and referral algorithm to locate the proper child mental-health specialist. 
Overall, providers felt that being more aware of the potential referrals and resources in the 
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community will improve their management of children, ages 4-11, with ADHD. Knowledge of 
community resources and referrals by providers in past project studies were not previously 
reported.  
Objective 3: Promote the utilization of resources and referrals that are available in 
the community. The project was evaluated by the questionnaires that each care provider was 
given after participating in the PIP. Participating providers felt that the treatment-guideline 
packet addressed a need in practice and made them more aware of potential referrals and 
resources in the community. Approximately 50% (n=3) of the FNP providers expressed that 
they are new in practice and do not have a large pediatric clientele at this time, but they felt that 
the packet would benefit them later in practice when seeing more pediatric patients. One 
provider felt that it would improve the quality of care with the access of referrals and resources 
by enhancing the ability to treat promptly and adequately when managing ADHD in children 
who are 4-11 years of age. Another provider felt the packet was easy to utilize and perceived no 
barriers. One provider stated that appointments were made by staff and that she did not decide 
who the appointment was made with unless specified. The provider did feel that she can now 
use the resource/referral algorithm to specify what resources or whom to refer for specific 
treatments. Last, one provider felt that a barrier in practice was the facility referring within its 
own network.  
Objective 4: Present an ADHD treatment-guideline packet to 5 NPs and 1 
pediatrician who specialize in ADHD in the region; the packet has the AAP guideline 
algorithm and an algorithm listing the available community resources and referrals. The 
packet contained an AAP ADHD process-of-care algorithm and a community referral/resource 
algorithm for the management of 4-11 year old children with ADHD symptoms. At the 
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completion of the 6-week trial period, the packet was tested to discover if the easily accessible 
evidence-based guidelines assisted providers with the management of children who were 4-
11years of age and had ADHD. The packet was found to be beneficial and did address a need in 
practice for 100% of the study participants. 
Objective 5: Evaluate the packet’s usefulness as a resource for the FNPs and other 
primary-care providers when managing ADHD in children. Of the providers, 100% (n=6) 
felt that the treatment-guideline packet would be beneficial and a useful tool in practice. Of the 
participant providers, 2 of the 6 felt that the treatment-guideline packet was succinct and 
provided an easy-and-quick reference. To improve the packet with evidence-based guidelines, 
three-fourths of the providers felt that adding the Vanderbilt assessment scales for diagnosing 
children would be beneficial. One provider recommended adding the Patient Health 
Questionnaire-9 (PHQ9), which is a depression scale and the Pediatric Symptom Checklist-17 
(PSC-17) to screen for behavioral disorders in addition to the Vanderbilt assessment scales to 
assist with screening for comorbidities and to rule out other mental-health disorders.  
Key Barriers 
Healthcare providers across the country are seeking ways to improve patient care and 
practice. With any improvements in care, there are barriers. According to the American 
Academy of Child and Adolescent Psychiatry (AACAP), one important barrier for healthcare is 
reducing administrative and financial barriers to access and to collaborate with resources in the 
community (AACAP, 2009). According to the surgeon general's report in 2009, there is a 
challenge for gaining access to mental-health services when there is a shortage of children's 
mental-health professionals, making collaboration and coordination of resources and care even 
more necessary with PCPs (AACAP, 2009). With the use of a treatment-guideline packet which 
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contains the most recent treatment guidelines for children with ADHD and the community 
resources available, there is hope to improve both the collaboration and coordination of 
resources and mental-health specialists with the PCP.  
One of the barriers for some of the FNPs who participated in the PIP was not being in 
practice very long and not having a large pediatric population. Providers who have low pediatric 
populations may forget the packet is available as a resource. Another potential barrier for 
widespread use of the packet is the need for frequent updates to reflect the most recent resources 
or proper referrals within the community. Inviting providers who see children to use the packet 
in practice would be ideal. More providers utilizing the packet and then participating with its 
updates and improvements may increase the acceptance and utilization rates. Adopting the use 
of the provider packet may be a challenge for providers who do not have the time or interest. 
According the AACAP (2009) with the appropriate training and collaborative relationships, the 
PCP should be able to properly manage children with common mental-health disorders such as 
attention deficit/hyperactivity disorder (ADHD).  
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CHAPTER 6. DISCUSSION 
Interpretation of Results 
The literature review illustrated the growing concern about the proper diagnosis, 
management, and referral of children with ADHD. The PDSA cycle model provided feedback 
from the project study by testing the change in practice and then carefully observing and 
learning from the study, while providing the researcher with the needed modifications to 
improve the packet. The Plan cycle involved the researcher creating a clinical-practice guideline 
packet to be tested in rural communities by providers. The Do cycle put the packet into practice 
to be utilized by the providers. The Study cycle of the project involved receiving feedback with 
a 7-point post-questionnaire for providers to complete after having the opportunity to utilize the 
resource/referral guideline for managing children who were 4-11 years of age. The 
questionnaire was developed specifically to allow the researcher to recognize how the packet 
was useful in practice and how the packet might be improved.  
The PDSA improvement model provided the researcher with evidence that a provider-
ready algorithm along with evidence-based resources that assisted providers in the management 
of children with ADHD, was a need and benefited practice. The questionnaire found that all 
providers felt that the pamphlet guideline would be useful and could benefit practice. Using a 
packet that contains both a resource/referral algorithm and an evidence-based ADHD process-
of-care algorithm from the AAP gave providers the knowledge of up-to-date treatment 
guidelines and the available community resources and referrals. Lastly, the Act cycle of the 
PDSA model allowed feedback on improvements to benefit the packet in practice. With packet 
improvements based on the questionnaire, the next step is to make the improvements and decide 
to continue with full implementation. 
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Limitations 
The major limitations of the practice-improvement project were time and the sample 
size.  The time given to providers was 6 weeks, limiting their opportunity to use and become 
familiar with the resource/referral guideline. Provider selection was limited because of the small 
number of family nurse practitioners who saw children in these rural communities. The project 
implementation was completed in the spring of year which may have been another limitation.  
Children with ADHD symptoms may have been assessed more in the fall of the year at the 
beginning of the school year when symptoms were first noticed by educators. Additionally, the 
time limitation restricted providers’ ability to use the packet because some of them did not see a 
pediatric patient who exhibited ADHD symptoms during the project’s implementation. 
Extending the use of the treatment-guideline packet on a trial basis to all providers in a position 
to assess and manage children with ADHD symptoms would have been ideal, but that step was 
felt to be too time consuming and outside the project’s scope.  
Implication for Practice 
The nurse practitioner may have the first contact with a child who exhibits symptoms of 
ADHD.  The management of ADHD will have a profound impact on healthcare today and in the 
future. With prompt and adequate detection of ADHD symptoms, the child will be diagnosed 
and treated properly. The nurse practitioner is a professional, an important player in healthcare 
of patients, and a needed participant in professional healthcare organizations to stay current on 
evidence-based treatment guidelines that affect the health of individuals and communities.  
The resource/referral algorithm was developed by the researcher in collaboration with 
child mental-health specialists and facilities in the communities to assist providers who assess 
and manage 4-11 year old children with ADHD. The questionnaire was developed by the 
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researcher to assess whether the PIP objectives were met. The packet’s reliability was not 
established before implementation. However, the practice-improvement project (PIP) 
demonstrated that a treatment guideline with a resource/referral algorithm and an evidence-
based ADHD process-of-care algorithm was an effective tool to use in practice to meet the 
ongoing professional-development needs of primary-care providers. The information collected 
from this project can be used by providers for both the individual needs of the patient and the 
patient’s family. The project provided guidance about the care of a child with ADHD, focusing 
on evidence-based, high-quality treatment obtained in a timely manner.  
Recommendation and Application for Practice 
Early intervention and management for children with ADHD symptoms is important and 
should be addressed at each visit, such as a well-child visit. The primary-care settings allow 
opportunities for providers who are in positions to evaluate children with ADHD symptoms for 
early identification and intervention, counseling, guidance, care coordination, and chronic 
illness management (AACAP, 2009). The treatment-guideline packet was developed to assist 
providers with accessing the proper resources and referrals in the community to manage these 
children appropriately. In a review of literature search, studies involving community 
resource/referral guides for primary-care providers were not found. The increased prevalence of 
ADHD suggested that children with the disorder would have high rates of health-related 
services, including increased use of community resources (Leslie & Wolraich, 2007). An 
increased use of resources and referrals leads to increased costs for healthcare. According to the 
AACAP (2009), healthcare policy needs to support the primary care clinician. Additional 
support of FNP’s involvement in all mental-health care can be facilitated by adopting payment 
for assessment and treatment that is equal or comparable with payment of services of other 
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medical illnesses. According to Leslie and Wolraich (2007), providers understanding of service 
use and availability, will allow for resource planning and allocation for costs as well as better 
tailoring of guidelines by professional organizations. 
  The providers who participated in the PIP felt that the packet was useful in practice by 
providing awareness regarding the available community resources to effectively treat these 
children. The author’s recommendations include adding the Vanderbilt assessment scales for 
children and updating the guideline yearly to ensure that the providers and resources are current. 
Care teams and care managers may be the key players in delegating other team players such as 
receptionists, to update the community resources. Future research should evaluate the 
importance of having the knowledge of resources and referrals available in all communities for 
the appropriate treatment according to clinical-based guidelines. Upon completion, information 
from the PIP will be shared with the participants to help improve practice. Based on the author’s 
recommendations, the participant providers can decide how resources and referrals will be 
updated and whether the treatment-guideline packet should continue to be used in practice. 
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APPENDIX A. ADHD PROCESS OF CARE ALGORITHM
Overview of the 
ADHD Care Process 
1 
 
4- to 18- y-old patient identified with signs or symptoms suggesting ADHD. 
Symptoms can come from parents’ direct concerns or the mental health screen recommended by the TFOMH 
See TFOMH Algorithms 
See action statement 1 
 
 
 
2 
Family 
Perform Diagnostic Evaluation for ADHD and Evaluate or Screen for Other/Coexisting Conditions: 
See action statements 2–3 
(parents, guardian, other frequent caregivers): 
• Chief concerns 
• History of symptoms (eg, age of onset and 
course over time) 
• Family history 
• Past medical history 
• Psychosocial history 
• Review of systems 
• Validated ADHD instrument 
• Evaluation of coexisting conditions 
• Report of function, both strengths and 
weaknesses 
 
School 
(and important community informants): 
• Concerns 
• Validated ADHD instrument 
• Evaluation of coexisting conditions 
• Report on how well patients function in 
academic, work, and social interactions 
• Academic records (eg, report cards, 
standardized testing, psychoeducational 
evaluations) 
• Administrative reports (eg, disciplinary actions) 
 
Child/adolescent 
(as appropriate for child’s age and 
developmental status): 
• Interview, including concerns regarding 
behavior, family relationships, peers, school 
• For adolescents: validated self-report 
instrument of ADHD and coexisting conditions 
• Report of child’s self-identified impression 
of function, both strengths and weaknesses 
• Clinician’s observations of child’s behavior 
• Physical and neurologic  examination 
 
 
3 
DSM-IV 
 
Yes 
4 
  Coexisting 
 
Yes 
5 
Assess impact on 
diagnosis of 
ADHD? 
 
No 
6 
Other 
 
 
 
7 
Yes 
 
 
 
Exit this guideline. 
Evaluate or refer, as 
appropriate. 
                Conditions?  
 
No 
8 
 
See action 
statement 3 
treatment plan 
Further evaluation/ 
referral as needed 
 
 
 
9 
condition? 
 
 
No 
 
10 
Identify the child as 
CYSHCN if 
appropriate. 
 
 
11 Inattention and/or 
Provide education to family and child 
re: concerns (eg, triggers for 
inattention or hyperactivity) and No 
behavior-management strategies 
or school-based strategies 
 
 Coexisting disorders 
preclude primary care 
management? 
Apparently 
typical or 
developmental 
variation? 
 
 
Yes 
No hyperactivity/impulsivity problems not rising to 
DSM-IV diagnosis 
Provide education of family and 12 
child re: concerns (eg, triggers for 
inattention or hyperactivity) and 
behavior management strategies 
 
 
 
 
ESTABLISH MANAGEMENT TEAM 
Collaborate with 
 
 
Yes 
13 
 
Follow-up and 
establish co- 
 
14 
 
Provide education 
or school-based strategies
 
Enhanced 
Surveillance 
 
Identify child as 
CYSHCN 
family, school, 
and child to 
identify target 
goals. 
Establish team 
including 
coordination plan 
management plan 
See TFOMH 
Algorithms 
addressing concern (eg, 
expectations for attention 
as a function of age) 
Enhanced 
Surveillance 
 
15 
 
 
Option: Medication (ADHD only 
and past medical or family 
history of cardiovascular disease 
considered) 
• Initiate treatment 
• Titrate to maximum benefit, 
minimum adverse effects 
• Monitor target  outcomes 
 
 
BEGIN TREATMENT 
See action statement 5 
 
Option: Behavior management 
(developmental variation, 
problem or ADHD) 
• Identify service or approach 
• Monitor target  outcomes 
 
 
 
 
 
Option: Collaborate with 
school to enhance supports 
and services (developmental 
variation, problem, or ADHD) 
• Identify changes 
• Monitor target  outcomes 
 
See action statement 6 
 
16 17 
 
                     Do         No 
         symptoms 
improve? 
             
 
                               Yes 
 
      Follow-up 18 chronic care 
management at 
least 2x/year for 
ADHD issues 
 (AAP, 2011a). 
       diagnosis and/or provide     
          education to improve   
                           adherence. 
    Reconsider treatment plan 
including changing of the 
medication or dose, adding a   
medication approved for adjuvant 
therapy, and/or 
changing behavioral therapy. 
Legend 
= Start 
 
= Action/process 
 
= Decision 
 
= Continued car
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NDSU 
APPENDIX B. NORTH DAKOTA STATE UNIVERSITY IRB APPROVAL 
 
NORTH DAKOTA       
STATE UNIVERSITY 
September 25, 2013     Federal Wide Assurance FWA00002439  
Dr. Mykell Barnacle 
Nursing Sudro Hall 
Re: IRB Certification of Exempt Human Subjects Research: 
Protocol #PH14042, "PRIMARY CARE RESOURCE AND REFERRAL GUIDE FOR 
CHILDREN WITH ADHD" 
 
Co-investigator(s) and research team: Bonita Jenzen 
 
Certification Date: 9/25/2013 Expiration Date: 9/24/2016 
Study site(s): Detroit Lakes, Frazee, Perham, New York Mills, and Ottertail, MN Funding: n/a 
 
The above referenced human subjects research project has been certified as exempt (category # 
2) in accordance with federal regulations (Code of Federal Regulations, Title 45, Part 46, 
Protection of Human Subjects). This determination is based on protocol materials (received 
9/25/2013). 
 
Please also note the following: 
• If you wish to continue the research after the expiration, submit a request for recertification 
several weeks prior to the expiration. 
• Conduct the study as described in the approved protocol.  If you wish to make changes, obtain 
approval from the IRB prior to initiating, unless the changes are necessary to eliminate an 
immediate hazard to subjects. 
• Notify the IRB promptly of any adverse events, complaints, or unanticipated problems involving 
risks to subjects or others related to this project. 
• Report any significant new findings that may affect the risks and benefits to the participants and 
the IRB. 
• Research records may be subject to a random or directed audit at any time to verify compliance 
with IRB standard operating procedures. 
 
Thank you for your cooperation with NDSU IRB procedures. Best wishes for a successful study. 
Sincerely,  
 
Kristy Shirley, CIP, Research Compliance Administrator 
INSTITUTIONAL REVIEW BOARD 
NDSU Dept 4000   I  PO Box 6050   I  Fargo ND 58108-6050   I  701.231.8995   I  Fax 701.231.8098   I  ndsu.edu/irb 
 
Shipping address:  Research 1, 1735 NDSU Research Park Drive, Fargo, ND 58102 
NDSU is an EO/AA university. 
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APPENDIX C. SANFORD HEALTH HUMAN RESEARCH PROTECTION APPROVAL 
 
November 22, 2013 
 
PI: Mykell Barnacle, DNP 
Project:  03-13-140 Primary Care Resource and Referral Guide for Children 4-11 Years of Age with 
ADHD 
Project Review Level: Exempt 2 
Project Risk: No more than minimal 
Approved through exempt review:  11/22/2013 
The study submission and informed consent for the proposal referenced above has been 
reviewed and approved via the procedures of the Sanford Health Institutional Review 
Board (IRB). 
 
Attached is your original consent document that has been stamped with the IRB approval date.  
You must  keep this original on file.   Please use this original consent document to make copies 
for subject enrollment/re- consent.  No other consent form should be used. In addition, each 
subject must be given a copy of the consent form. 
 
Prior to initiation, promptly report to the IRB, any proposed project updates I amendments 
(e.g., protocol amendments/revised informed consents) in previously approved human 
subject research activities. 
 
The forms to assist you in filing your: project closure, continuation, adverse/unanticipated 
event, project updates /amendments, etc. can be accessed online at Sanford Connect. 
 
You have approval for this project starting from the approval date. Exempt projects do not 
expire; however, please update the IRB of your study status annually. Exempt projects can be 
closed when data collection is completed.  When this study is completed please notify the 
Human Research Protection office. 
 
Sincerely, 
 
Director-Sanford IRB Sanford Health Human  ResParch  Prorection  Program,  Roure # )033 • 1305 W. 18th Street • Sioux 
Fi·llls SD 5'l:l.J7-5039  • P 605-312-6430 
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APPENDIX D. ESSENTIA HEALTH INTERNAL REVIEW BOARD APPROVAL 
 
 
 
 
October 25, 2013 
 
 
To Whom It May Concern: 
 
I have been asked to review Bonita Jenzen’s DNP project proposal which plans to utilize an ADHD 
referral and resource algorithm with FNPs at Essentia Health over a 6-week period. Per our Student 
Learner Policy this project is a quality improvement project. As such, a submission to Essentia Health’s 
Internal Review Board is not necessary.  
 
If you have any further questions, please feel free to contact me at 218.786.3008 or kdean@eirh.org. 
We look forward to learning the results of Ms. Jenzen’s project and request that a copy of the final 
dissertation is submitted to me. We appreciate the opportunity to work with students from your 
program.   
  
Sincerely,  
 
 
Kate Dean, MBA 
Director Health Science and Graduate Medical Education 
Essentia Institute of Rural Health 
 
Ph: 218-786-3008 
Email: kdean@eirh.org 
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APPENDIX E. INFORMED CONSENT ESSENTIA HEALTH CARE 
North Dakota State University (NDSU) 
Nursing Department 2670 P.O. Box 6050 
Sudro Hall, Room 136 
Fargo, ND 58108 
(701) 231-7395 
 
Title of Clinical Practice Improvement Project: Primary Care Resource and Referral Guide for 
Children with ADHD. 
The Practice Improvement Project is conducted by: 
Bonita Jenzen, FNP-S, RN, NDSU Doctor of Nursing Practice Student 
(218) 405-0373 
bonita.jenzen@my.ndsu.edu 
 
Dr. Mykell Barnacle, RN, Doctoral of Nursing (DNP) (advisor & research chair) 
NDSU Nursing Department Assistant Professor 
 (701) 231-7730 
mykell.barnacle@ndsu.edu 
 
Dear Professional Colleagues, 
I’m Bonita Jenzen, a family nurse practitioner (FNP) student from NDSU.  As a student I 
will be doing a practice improvement project (PIP) regarding resources and referrals for children 
with symptoms of Attention Deficit Hyperactivity Disorder (ADHD).  The resources and 
referrals will be compiled into a pamphlet for FNPs in the communities of Detroit Lakes, Frazee, 
Perham, New York Mills, and Ottertail.  The project will highlight the importance of seeking 
proper referrals and resources in the community to correctly manage children 4-11 years of age 
with the symptoms of ADHD.  The pamphlet will provide you as a FNP information regarding 
professionals available for referral and the community resources that are available for the child 
with ADHD and their family.   
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I would like the opportunity to provide a pamphlet with a resource referral algorithm to 
FNPs in your facility.  The purpose of the project is to discover if the algorithm with current 
resources and referrals would help assist providers and ultimately improve practice. Participation 
is entirely voluntary and you may change your mind at any time. The information obtained will 
be combined with other data and will have no identifiers such as the participant’s name, age, or 
address.  
 Please contact me or my chair at bonita.jenzen@my.ndsu.edu or 
mykell.barnacle@ndsu.edu with any questions or concerns about this project, or to receive a 
copy of the results of this project. 
Thank You, 
 
Bonita Jenzen, RN, BSN 
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APPENDIX F. INFORMED CONSENT SANFORD HEALTH CARE 
 
North Dakota State University (NDSU) 
Nursing Department 2670 P.O. Box 6050 
Sudro Hall, Room 136 
Fargo, ND 58108 
(701) 231-7395 
 
Title of Clinical Practice Improvement Project: Primary Care Resource and Referral Guide for 
Children with ADHD. 
The Practice Improvement Project is conducted by: 
Bonita Jenzen, FNP-S, RN, NDSU Doctor of Nursing Practice Student 
(218) 405-0373 
bonita.jenzen@my.ndsu.edu 
 
Dr. Mykell Barnacle, RN, Doctoral of Nursing (DNP) (advisor & research chair) 
NDSU Nursing Department Assistant Professor 
 (701) 231-7730 
mykell.barnacle@ndsu.edu 
 
Dear Professional Colleagues, 
I’m Bonita Jenzen, a family nurse practitioner (FNP) student from NDSU.  As a student I 
will be doing a practice improvement project (PIP) regarding resources and referrals for children 
with symptoms of Attention Deficit Hyperactivity Disorder (ADHD).  The resources and 
referrals will be compiled into a pamphlet for FNPs in the communities of Detroit Lakes, Frazee, 
Perham, New York Mills, and Ottertail.  The project will highlight the importance of seeking 
proper referrals and resources in the community to correctly manage children 4-11 years of age 
with the symptoms of ADHD.  The pamphlet will provide you as a FNP information regarding 
professionals available for referral and the community resources that are available for the child 
with ADHD and their family.   
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I would like the opportunity to provide a pamphlet with a resource referral algorithm to 
FNPs in your facility.  The purpose of the project is to discover if the algorithm with current 
resources and referrals would help assist providers and ultimately improve practice. Participation 
is entirely voluntary and you may change your mind at any time. The information obtained will 
be combined with other data and will have no identifiers such as the participant’s name, age, or 
address.  
 Please contact me or my chair at bonita.jenzen@my.ndsu.edu or 
mykell.barnacle@ndsu.edu with any questions or concerns about this project, or to receive a 
copy of the results of this project. 
Thank You, 
 
Bonita Jenzen, RN, BSN 
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APPENDIX G.  MEDICATIONS 
Medications Created 2011(adapted from National Institute of Mental Health, 2011, p. 1) 
Trade Name Generic Name FDA- 
Approved 
Age 
Side Effects 
ADHD Medications  
(All ADHD medications are  
stimulants, except Intuniv and 
Straterra.) 
  
Short-acting medicines 
require frequent dosing but 
longer-acting meds which 
are more convenient may 
have a greater effect on 
appetite and sleep. 
Adderall amphetamine  3 and older Loss of appetite, weight loss, 
sleep problems, irritability, 
tics, and personality changes 
Adderall XR amphetamine (extended 
release) 
6 and older Loss of appetite, weight loss, 
sleep problems, irritability, 
tics, and personality changes 
Concerta methylphenidate (long 
acting) 
6 and older Losses of appetite, weight 
loss, sleep problems, 
irritability, tics, and 
personality changes. 
Daytrana methylphenidate patch 6 and older Skin irritation with patch but 
all may have some loss of 
appetite, weight loss, sleep 
problems, irritability, tics, 
and personality changes. 
Desoxyn methamphetamine 6 and older Loss of appetite, weight loss, 
sleep problems, irritability, 
tics, and personality 
changes. 
Dexedrine dextroamphetamine 3 and older Loss of appetite, weight loss, 
sleep problems, irritability, 
tics, and personality changes 
Dextrostat dextroamphetamine 3 and older Loss of appetite, weight loss, 
sleep problems, irritability, 
tics, and personality 
changes. 
Focalin dexmethylphenidate 6 and older Loss of appetite, weight loss, 
sleep problems, irritability, 
tics, and personality 
changes. 
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Trade Name Generic Name FDA- 
Approved 
Age 
Side Effects 
Focalin XR dexmethylphenidate 
(extended release) 
6 and older Loss of appetite, weight loss, 
sleep problems, irritability, 
tics, and personality 
problems. 
Intuniv 
 
(non-stimulant) 
guanfacine 6 and older Sleepiness, headache, 
fatigue, abdominal pain.  
Rarely, Intuniv can cause 
low blood pressure and heart 
rhythm changes. 
Metadate ER methylphenidate (extended 
release) 
6 and older Loss of appetite, weight loss, 
sleep problems, irritability, 
tics, and personality changes 
Metadate CD methylphenidate (extended 
release) 
6 and older Loss of appetite, weight loss, 
sleep problems, irritability, 
tics, and personality changes. 
Methylin methylphenidate (oral 
solution and chewable 
tablets) 
6 and older Loss of appetite, weight loss, 
sleep problems, irritability, 
tics, and personality changes. 
Ritalin methylphenidate 6 and older Loss of appetite, weight loss, 
sleep problems, irritability, 
tics, and personality changes 
Ritalin SR methylphenidate (extended 
release) 
6 and older Loss of appetite, weight loss, 
sleep problems, irritability, 
tics, and personality changes. 
Ritalin LA methylphenidate (long-
acting) 
6 and older Loss of appetite, weight loss, 
sleep problems, irritability, 
tics, and personality changes. 
Strattera 
 
(non-stimulant) 
atomoxetine 6 and older Sleep problems, anxiety, 
fatigue, upset stomach, 
dizziness, dry mouth. Rarely, 
liver damage. some concerns 
of suicidal thoughts and 
personality changes 
Vyvanse lisdexamfetamine 
dimesylate 
6 and older Loss of appetite, weight loss, 
sleep problems, irritability, 
tics, and personality changes. 
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APPENDIX H. ADHD REFERRAL/RESOURCE ALGORITHM
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APPENDIX I. ADHD REFERRAL/RESOURCE KEY 
 
Key 
CNS-Certified Nurse Specialist can diagnose, test and prescribe medications. 
CTSS-(Children Therapeutic Services and Supports) is a program with in the home to 
promote emotional and behavioral stability for children and their families.  The program 
aims to provide the skills to strengthen the child and the family, by increasing parental 
skills which enable the parents to work more effective with the child in the home, the 
school and in the community.  
IIT-(Family Intensive in Home Therapy). 
IVA-Integrated Visual and Auditory Continuous Performance Test.  The test assists 
clinicians in the screening and management of children by providing objective data on 
ones concentrate impulsive decisions. 
MSW-Master of Science of Social Work. 
LICSW-License Social Worker who specializes in children with mental health disorders 
can treat with Cognitive Behavioral Therapy. 
LGSW- License Graduate Social Worker who works under the LICSW and specializes in 
children with mental health disorders can treat with Cognitive Behavioral Therapy. 
LMHC-Lakeland Mental Health Center. 
T.O.V.A.-Test of Variables of Attention. TOVA is a computerized test of attention.  The 
test is to assist the clinician in the screening and the management of attention disorders, 
like Attention Deficit Hyperactivity Disorder (ADHD). 
 
   
63 
 
 
APPENDIX J. POST-QUESTIONNAIRE 
POST-QUESTIONNAIRE FOR THE RESOURCE/REFERAL GUIDE FOR CHILDREN WITH 
ADHD 
 
1. How many children 4-11 years of age with the symptoms of ADHD have you seen in the last 6 
weeks? 
 
 
 
2. What was the primary reason for seeing the child who you determined had the symptoms of 
ADHD? 
 
 
 
3. Do you feel that the algorithm packet addresses a need in your practice? If so, how?  If not, 
why not? 
 
 
 
4. In what way(s) did the packet benefit or improve practice? 
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5. In what way(s) did the packet not benefit your practice? 
 
 
 
 
6. What barriers did you encounter or do you foresee when using the algorithm? 
 
 
 
 
7. What are your professional feelings regarding how to improve the packet in practice? 
 
 
 
 
 
 
 
 
 
